Search research articles
Contact Us
Filters
Showing results (61-70 of 89) with videos related to
Page
of 9
Sort By:
The Mount Sinai Journal of Medicine, New York
|
May 1, 1983
Pretreatment marrow cytogenetic status: a predictor of response to remission induction therapy in acute myelogenous leukemia
M S Conjalka, J Cuttner, L Wisniewski, et al.
The Journal of Experimental Medicine
|
June 1, 1987
High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase
S V Seremetis, P G Pelicci, A Tabilio, et al.
Leukemia Research
|
January 1, 1986
The reproducibility of acute lymphoblastic leukemia phenotype determinations: evaluation of monoclonal antibody and conventional hematopoietic markers
R E Sobol, R Mick, T W LeBien, et al.
The New England Journal of Medicine
|
April 30, 1987
Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia
R E Sobol, R Mick, I Royston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1988
Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B Study
R L Capizzi, R Davis, B Powell, et al.
Cancer
|
January 1, 1981
The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study
H H Hansen, O S Selawry, T F Pajak, et al.
Leukemia Research
|
January 1, 1984
Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: studies of patients with clonal hematopoietic neoplasia
J W Singer, A Keating, J Cuttner, et al.
The Journal of Clinical Investigation
|
April 1, 1987
Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed
I D Bernstein, J W Singer, R G Andrews, et al.
Cancer Clinical Trials
|
January 1, 1981
MER immunotherapy and combination chemotherapy for advanced, recurrent Hodgkin's disease. Cancer and Leukemia Group B study
V Vinciguerra, M Coleman, T F Pajak, et al.
Blood
|
July 1, 1984
Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B
A J Gottlieb, V Weinberg, R R Ellison, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 89) with videos related to
Sort By:
Page
of 9
The Mount Sinai Journal of Medicine, New York
|
May 1, 1983
Pretreatment marrow cytogenetic status: a predictor of response to remission induction therapy in acute myelogenous leukemia
M S Conjalka, J Cuttner, L Wisniewski, et al.
The Journal of Experimental Medicine
|
June 1, 1987
High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase
S V Seremetis, P G Pelicci, A Tabilio, et al.
Leukemia Research
|
January 1, 1986
The reproducibility of acute lymphoblastic leukemia phenotype determinations: evaluation of monoclonal antibody and conventional hematopoietic markers
R E Sobol, R Mick, T W LeBien, et al.
The New England Journal of Medicine
|
April 30, 1987
Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia
R E Sobol, R Mick, I Royston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1988
Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B Study
R L Capizzi, R Davis, B Powell, et al.
Cancer
|
January 1, 1981
The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study
H H Hansen, O S Selawry, T F Pajak, et al.
Leukemia Research
|
January 1, 1984
Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: studies of patients with clonal hematopoietic neoplasia
J W Singer, A Keating, J Cuttner, et al.
The Journal of Clinical Investigation
|
April 1, 1987
Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed
I D Bernstein, J W Singer, R G Andrews, et al.
Cancer Clinical Trials
|
January 1, 1981
MER immunotherapy and combination chemotherapy for advanced, recurrent Hodgkin's disease. Cancer and Leukemia Group B study
V Vinciguerra, M Coleman, T F Pajak, et al.
Blood
|
July 1, 1984
Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B
A J Gottlieb, V Weinberg, R R Ellison, et al.
Page
of 9